Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2Plasma cell 1

Conditions

Inflammatory Breast Neoplasms 1Breast Neoplasms 1

Interventions

Trastuzumab 697Paclitaxel 680Cyclophosphamide 635Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × 89Zr-bevacizumab × Breast × Clear all
NCT01894451 2019-12-12

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Completed
2 enrolled
Breast

Inflammatory Breast Neoplasms

NCT00991978 2012-03-30

VEGF Early Imaging for Breast Cancer

University Medical Center Groningen

Phase EARLY_PHASE1 Completed
23 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡